Epidermolysis bullosa: treatment and prevention

Abstract

Congenital epidermolysis bullosa is considered as a phenotypically and genetically heterogeneous group of genodermatoses caused by various mutations in the genes that control the synthesis of structural proteins of the skin, carrying out epider­mal-dermal bonds. In this article, we aimed to indicate the polymorphism of clinical manifestations of epidermolysis bullosa, which must be confirmed by immunohistochemical studies. Numerous literature data were used on the clinical variants of epidermolysis bullosa, which consider not only 4 classical forms of the disease (simple, boundary, dystrophic and Kindlers syndrome), but also subtypes of each form of genoderma­tosis. Separately we discussed issues related to conducting immunohistological research in various forms of epidermolysis bullosa, when the localization of such protein components as collagen type IV, laminin and others was determined with the help of special antiserums. It was noted that the gold standard for histological examination in patients with epidermolysis bullosa is immunohistological methods that allow determining the deposition of immunoglobulins and complement components in the skin by means of the immunofluorescence method. Each nosological form of epidermolysis bullosa has genetic (study of genealogical charts) features of inheritance and an immunohistologic characteristic, which makes it possible to conduct differential diagnostics with other varieties of epidermolysis bullosa. Not in all cases, the clinical findings of epidermolysis bullosa can help to make the correct diagnosis and determine the specific form of epidermolysis bullosa. In this regard, additional research methods are important, including genetic ones, conducted in the process of adequate symptomatic therapy.

Authors and Affiliations

A. B. Rakhmatov

Keywords

Related Articles

Potentials of contemporary biomarkers in assessing skin lesions and fibrous activity in systemic scleroderma

Systemic scleroderma (SSD) is a systemic disease with heterogeneous clinical manifestations of skin and internal organs lesions. It is believed that the trigger for its development is the initial damage of the blood vess...

Some aspects of use of desloratadine in treatment of chronic urticaria

Objecive — to investigate the clinical effectiveness of the antihistamine of II- generation Eslotin (desloratadine) in the treatment of chronic urticaria, the effect on the quality of life and the safety of therapy of p...

Indices of lipid metabolism in patients with psoriasis of autumn-­winter, spring­-summer and off-­season (mixed) flow types and their significance in the pathogenesis of dermatosis

Objective — to analyze the features of the lipid spectrum in the blood and skin of patients with psoriasis of autumn­-winter, spring-­­summer and off-­season (mixed) flow types and to determine the significance of lipid...

Download PDF file
  • EP ID EP577200
  • DOI 10.30978/UJDVK2019-1-36
  • Views 122
  • Downloads 0

How To Cite

A. B. Rakhmatov (2019). Epidermolysis bullosa: treatment and prevention. Український журнал дерматології, венерології, косметології, 0(1), 36-45. https://europub.co.uk/articles/-A-577200